Cargando…
Interleukin-18 Promoter Gene Polymorphisms are not Associated with Myocardial Infarction in Type 2 Diabetes in Slovenia
Type 2 diabetes is a major risk factor for myocardial infarction (MI) and chronic inflammation may play a central role in both diseases. Interleukin (IL)-18 is a potent proinflammatory cytokine, which is considered important in acute coronary syndromes and type 2 diabetes. We investigated the associ...
Autores principales: | Kariž, S, Petrovič, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Macedonian Science of Sciences and Arts
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776693/ https://www.ncbi.nlm.nih.gov/pubmed/24052696 http://dx.doi.org/10.2478/v10034-011-0011-6 |
Ejemplares similares
-
PECAM-1 Leu125Val (rs688) Polymorphism and Diabetic Nephropathy in Caucasians with Type 2 Diabetes Mellitus
por: Završnik, Matej, et al.
Publicado: (2016) -
The rs3825807 Polymorphism of ADAMTS7 as a Potential Genetic Marker for Myocardial Infarction in Slovenian Subjects with Type 2 Diabetes Mellitus
por: Petrovič, David, et al.
Publicado: (2023) -
Interleukin-6 gene −572 G > C polymorphism and myocardial infarction risk
por: Ding, He-guo, et al.
Publicado: (2020) -
Influence of interleukin-1β gene polymorphism on the risk of myocardial infarction complicated with ischemic stroke
por: Chen, Lei, et al.
Publicado: (2018) -
Predisposition to Myocardial Infarction Influenced by Interleukin 13 Gene Polymorphisms: A Case-Control Study
por: Hosseini, Seyyed Fatemeh, et al.
Publicado: (2022)